Potassium-Sparing Diuretics Market Analysis

Application (Edema, Hypertension, Heart Failure, Liver Cirrhosis)

The global potassium-sparing diuretics market is segmented and analyzed for demand and supply by application in edema, hypertension, heart failure, liver cirrhosis and others. Out of these, the hypertension segment is estimated to gain the largest market share of about 32% in the year 2037. The growth of the segment can be attributed to the increasing prevalence of hypertension globally owing to rising obesity and unhealthy and sedentary lifestyle habits. Approximately 60% of U.S. adults do not participate in the recommended amount of physical activity. It is estimated that 25 percent of U.S. adults are not physically active at all. Unhealthy lifestyle habits such as lack of physical activity, unhealthy dietary habits, smoking and alcohol consumption have been associated with increasing levels of obesity, which in turn increases the risk of hypertension. Additionally, increasing government initiatives for preventative healthcare and awareness about hypertension and its risk factors are also expected to contribute to the growth of this segment.

Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

The global potassium-sparing diuretics market is segmented and analyzed for demand and supply by distribution channel into hospital pharmacies, retail pharmacies, online pharmacies and others. Out of these, the hospital pharmacies segment is estimated to gain a significant market share of about 29% in the year 2037. The hospital pharmacies segment is expected to grow at a rapid pace owing to the increasing demand for generic drugs in hospitals, rising number of surgeries, and increasing spending capacity on healthcare in developing countries. Moreover, hospital pharmacies have access to more specialized equipment and a wider range of medications than regular pharmacies, which allows them to provide more tailored medication to their patients, resulting in a growing number of hospitals with specialty pharmacies. It was observed that more than 21% of hospitals have specialty pharmacies in 2018, up from less than 8% in 2016. Furthermore, rising investments in healthcare infrastructure and the presence of a large number of hospitals in urban and rural areas are also expected to drive the growth of the segment.

Our in-depth analysis of the global market includes the following segments: